Interest Expense in USD of Aquestive Therapeutics, Inc. from Q2 2017 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of the cost of borrowed funds accounted for as interest expense.
Summary
Aquestive Therapeutics, Inc. quarterly/annual Interest Expense history and change rate from Q2 2017 to Q2 2024.
  • Aquestive Therapeutics, Inc. Interest Expense for the quarter ending 30 Jun 2024 was $2.78M, a 102% increase year-over-year.
  • Aquestive Therapeutics, Inc. Interest Expense for the twelve months ending 30 Jun 2024 was $9.09M, a 48.9% increase year-over-year.
  • Aquestive Therapeutics, Inc. annual Interest Expense for 2023 was $6.34M, a 3.28% decline from 2022.
  • Aquestive Therapeutics, Inc. annual Interest Expense for 2022 was $6.55M, a 34.8% decline from 2021.
  • Aquestive Therapeutics, Inc. annual Interest Expense for 2021 was $10M, a 9.17% decline from 2020.
Interest Expense, Trailing 12 Months (USD)
Interest Expense, Quarterly (USD)
Interest Expense, YoY Quarterly Change (%)
Interest Expense, Annual (USD)
Interest Expense, YoY Annual Change (%)

Aquestive Therapeutics, Inc. Quarterly Interest Expense (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 $9.09M $2.78M +$1.41M +102% 01 Apr 2024 30 Jun 2024 10-Q 06 Aug 2024
Q1 2024 $7.69M $2.78M +$1.35M +94% 01 Jan 2024 31 Mar 2024 10-Q 07 May 2024
Q4 2023 $6.34M $2.27M +$623K +37.8% 01 Oct 2023 31 Dec 2023 10-K 05 Mar 2024
Q3 2023 $5.71M $1.26M -$393K -23.8% 01 Jul 2023 30 Sep 2023 10-Q 06 Nov 2023
Q2 2023 $6.11M $1.37M -$262K -16% 01 Apr 2023 30 Jun 2023 10-Q 06 Aug 2024
Q1 2023 $6.37M $1.44M -$183K -11.3% 01 Jan 2023 31 Mar 2023 10-Q 07 May 2024
Q4 2022 $6.55M $1.65M -$94K -5.39% 01 Oct 2022 31 Dec 2022 10-K 05 Mar 2024
Q3 2022 $6.65M $1.65M -$1.14M -40.8% 01 Jul 2022 30 Sep 2022 10-Q 06 Nov 2023
Q2 2022 $7.78M $1.64M -$1.12M -40.7% 01 Apr 2022 30 Jun 2022 10-Q 07 Aug 2023
Q1 2022 $8.91M $1.62M -$1.14M -41.4% 01 Jan 2022 31 Mar 2022 10-Q 02 May 2023
Q4 2021 $10M $1.74M -$1.02M -37% 01 Oct 2021 31 Dec 2021 10-K 31 Mar 2023
Q3 2021 $11.1M $2.79M +$9K +0.32% 01 Jul 2021 30 Sep 2021 10-Q 01 Nov 2022
Q2 2021 $11.1M $2.76M +$10K +0.36% 01 Apr 2021 30 Jun 2021 10-Q 02 Aug 2022
Q1 2021 $11.1M $2.76M -$10K -0.36% 01 Jan 2021 31 Mar 2021 10-Q 04 May 2022
Q4 2020 $11.1M $2.77M -$35K -1.25% 01 Oct 2020 31 Dec 2020 10-K 08 Mar 2022
Q3 2020 $11.1M $2.78M +$126K +4.75% 01 Jul 2020 30 Sep 2020 10-Q 02 Nov 2021
Q2 2020 $11M $2.75M +$810K +41.8% 01 Apr 2020 30 Jun 2020 10-Q 03 Aug 2021
Q1 2020 $10.2M $2.77M +$845K +43.9% 01 Jan 2020 31 Mar 2020 10-Q 04 May 2021
Q4 2019 $9.32M $2.8M +$879K +45.7% 01 Oct 2019 31 Dec 2019 10-K 09 Mar 2021
Q3 2019 $8.44M $2.65M +$719K +37.2% 01 Jul 2019 30 Sep 2019 10-Q 04 Nov 2020
Q2 2019 $7.72M $1.94M +$10K +0.52% 01 Apr 2019 30 Jun 2019 10-Q 04 Aug 2020
Q1 2019 $7.71M $1.93M -$1K -0.05% 01 Jan 2019 31 Mar 2019 10-Q 05 May 2020
Q4 2018 $7.71M $1.92M 01 Oct 2018 31 Dec 2018 10-K 11 Mar 2020
Q3 2018 $1.93M -$37K -1.88% 01 Jul 2018 30 Sep 2018 10-Q 05 Nov 2019
Q2 2018 $1.93M -$22K -1.13% 01 Apr 2018 30 Jun 2018 10-Q 06 Aug 2019
Q1 2018 $1.93M 01 Jan 2018 31 Mar 2018 10-Q 08 May 2019
Q3 2017 $1.97M 01 Jul 2017 30 Sep 2017 10-Q 06 Nov 2018
Q2 2017 $1.95M 01 Apr 2017 30 Jun 2017 10-Q 04 Sep 2018

Aquestive Therapeutics, Inc. Annual Interest Expense (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $6.34M -$215K -3.28% 01 Jan 2023 31 Dec 2023 10-K 05 Mar 2024
2022 $6.55M -$3.5M -34.8% 01 Jan 2022 31 Dec 2022 10-K 05 Mar 2024
2021 $10M -$1.02M -9.17% 01 Jan 2021 31 Dec 2021 10-K 31 Mar 2023
2020 $11.1M +$1.75M +18.7% 01 Jan 2020 31 Dec 2020 10-K 08 Mar 2022
2019 $9.32M +$1.61M +20.8% 01 Jan 2019 31 Dec 2019 10-K 09 Mar 2021
2018 $7.71M +$4K +0.05% 01 Jan 2018 31 Dec 2018 10-K 11 Mar 2020
2017 $7.71M 01 Jan 2017 31 Dec 2017 10-K 14 Mar 2019
* An asterisk sign (*) next to the value indicates that the value is likely invalid.